Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mallia

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2015
Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbationsDavid J Jackson, Nicholas Glanville, Maria-Belen Trujillo-Torralbo, et al.
Chest|February 22, 2014
Soluble major histocompatibility complex class I-related chain B molecules are increased and correlate with clinical outcomes during rhinovirus infection in healthy subjectsAurica G Telcian, Mihnea T Zdrenghea, Gaetano Caramori, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2014
Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligandMaria Tsoumakidou, Sofia Tousa, Maria Semitekolou, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 productionSimon D Message, Vasile Laza-Stanca, Patrick Mallia, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 19, 2024
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary diseaseLydia J Finney, Peter Fenwick, Samuel V Kemp, et al.
Future Healthcare Journal|December 23, 2022
Recovering from COVID-19: lessons learnt from an intensive secondary care follow-up serviceKartik Kumar, Prashanthi Ratnakumar, Piera Ricci, et al.
American Journal of Respiratory and Critical Care Medicine|October 5, 2010
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbationPatrick Mallia, Simon D Message, Vera Gielen, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2013
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary diseasePhilip L Molyneaux, Patrick Mallia, Michael J Cox, et al.
Chest|January 25, 2014
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthmaJie Zhu, Simon D Message, Yusheng Qiu, et al.
The Journal of Infectious Diseases|December 15, 2010
RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activityAurica G Telcian, Vasile Laza-Stanca, Michael R Edwards, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2015
Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbationsDavid J Jackson, Nicholas Glanville, Maria-Belen Trujillo-Torralbo, et al.
Chest|February 22, 2014
Soluble major histocompatibility complex class I-related chain B molecules are increased and correlate with clinical outcomes during rhinovirus infection in healthy subjectsAurica G Telcian, Mihnea T Zdrenghea, Gaetano Caramori, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2014
Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligandMaria Tsoumakidou, Sofia Tousa, Maria Semitekolou, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 productionSimon D Message, Vasile Laza-Stanca, Patrick Mallia, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 19, 2024
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary diseaseLydia J Finney, Peter Fenwick, Samuel V Kemp, et al.
Future Healthcare Journal|December 23, 2022
Recovering from COVID-19: lessons learnt from an intensive secondary care follow-up serviceKartik Kumar, Prashanthi Ratnakumar, Piera Ricci, et al.
American Journal of Respiratory and Critical Care Medicine|October 5, 2010
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbationPatrick Mallia, Simon D Message, Vera Gielen, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2013
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary diseasePhilip L Molyneaux, Patrick Mallia, Michael J Cox, et al.
Chest|January 25, 2014
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthmaJie Zhu, Simon D Message, Yusheng Qiu, et al.
The Journal of Infectious Diseases|December 15, 2010
RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activityAurica G Telcian, Vasile Laza-Stanca, Michael R Edwards, et al.
Pageof 9